268 related articles for article (PubMed ID: 10318773)
1. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.
Yu KY; Kwon B; Ni J; Zhai Y; Ebner R; Kwon BS
J Biol Chem; 1999 May; 274(20):13733-6. PubMed ID: 10318773
[TBL] [Abstract][Full Text] [Related]
2. Modulation of T-cell responses to alloantigens by TR6/DcR3.
Zhang J; Salcedo TW; Wan X; Ullrich S; Hu B; Gregorio T; Feng P; Qi S; Chen H; Cho YH; Li Y; Moore PA; Wu J
J Clin Invest; 2001 Jun; 107(11):1459-68. PubMed ID: 11390428
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of LIGHT and its receptors in human placental villi and amniochorion membranes.
Gill RM; Ni J; Hunt JS
Am J Pathol; 2002 Dec; 161(6):2011-7. PubMed ID: 12466117
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells.
Chang YH; Hsieh SL; Chao Y; Chou YC; Lin WW
J Biomed Sci; 2005; 12(2):363-75. PubMed ID: 15917993
[TBL] [Abstract][Full Text] [Related]
5. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer.
Zhai Y; Guo R; Hsu TL; Yu GL; Ni J; Kwon BS; Jiang GW; Lu J; Tan J; Ugustus M; Carter K; Rojas L; Zhu F; Lincoln C; Endress G; Xing L; Wang S; Oh KO; Gentz R; Ruben S; Lippman ME; Hsieh SL; Yang D
J Clin Invest; 1998 Sep; 102(6):1142-51. PubMed ID: 9739048
[TBL] [Abstract][Full Text] [Related]
6. A TNF family member LIGHT transduces costimulatory signals into human T cells.
Wan X; Zhang J; Luo H; Shi G; Kapnik E; Kim S; Kanakaraj P; Wu J
J Immunol; 2002 Dec; 169(12):6813-21. PubMed ID: 12471113
[TBL] [Abstract][Full Text] [Related]
7. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth.
Harrop JA; McDonnell PC; Brigham-Burke M; Lyn SD; Minton J; Tan KB; Dede K; Spampanato J; Silverman C; Hensley P; DiPrinzio R; Emery JG; Deen K; Eichman C; Chabot-Fletcher M; Truneh A; Young PR
J Biol Chem; 1998 Oct; 273(42):27548-56. PubMed ID: 9765287
[TBL] [Abstract][Full Text] [Related]
8. In vivo inhibition of Fas ligand-mediated killing by TR6, a Fas ligand decoy receptor.
Connolly K; Cho YH; Duan R; Fikes J; Gregorio T; LaFleur DW; Okoye Z; Salcedo TW; Santiago G; Ullrich S; Wei P; Windle K; Wong E; Yao XT; Zhang YQ; Zheng G; Moore PA
J Pharmacol Exp Ther; 2001 Jul; 298(1):25-33. PubMed ID: 11408521
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor.
Morel Y; Schiano de Colella JM; Harrop J; Deen KC; Holmes SD; Wattam TA; Khandekar SS; Truneh A; Sweet RW; Gastaut JA; Olive D; Costello RT
J Immunol; 2000 Oct; 165(8):4397-404. PubMed ID: 11035077
[TBL] [Abstract][Full Text] [Related]
10. LIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosis.
Matsui H; Hikichi Y; Tsuji I; Yamada T; Shintani Y
J Biol Chem; 2002 Dec; 277(51):50054-61. PubMed ID: 12393901
[TBL] [Abstract][Full Text] [Related]
11. Death decoy receptor TR6/DcR3 inhibits T cell chemotaxis in vitro and in vivo.
Shi G; Wu Y; Zhang J; Wu J
J Immunol; 2003 Oct; 171(7):3407-14. PubMed ID: 14500635
[TBL] [Abstract][Full Text] [Related]
12. Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT.
Wroblewski VJ; Witcher DR; Becker GW; Davis KA; Dou S; Micanovic R; Newton CM; Noblitt TW; Richardson JM; Song HY; Hale JE
Biochem Pharmacol; 2003 Feb; 65(4):657-67. PubMed ID: 12566095
[TBL] [Abstract][Full Text] [Related]
13. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.
Migone TS; Zhang J; Luo X; Zhuang L; Chen C; Hu B; Hong JS; Perry JW; Chen SF; Zhou JX; Cho YH; Ullrich S; Kanakaraj P; Carrell J; Boyd E; Olsen HS; Hu G; Pukac L; Liu D; Ni J; Kim S; Gentz R; Feng P; Moore PA; Ruben SM; Wei P
Immunity; 2002 Mar; 16(3):479-92. PubMed ID: 11911831
[TBL] [Abstract][Full Text] [Related]
14. Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling.
An MM; Fan KX; Zhang JD; Li HJ; Song SC; Liu BG; Gao PH; Zhou Q; Jiang YY
Pharmacol Res; 2005 Sep; 52(3):234-44. PubMed ID: 15925518
[TBL] [Abstract][Full Text] [Related]
15. Modulation of dendritic cell differentiation and maturation by decoy receptor 3.
Hsu TL; Chang YC; Chen SJ; Liu YJ; Chiu AW; Chio CC; Chen L; Hsieh SL
J Immunol; 2002 May; 168(10):4846-53. PubMed ID: 11994433
[TBL] [Abstract][Full Text] [Related]
16. Mouse T cells receive costimulatory signals from LIGHT, a TNF family member.
Shi G; Luo H; Wan X; Salcedo TW; Zhang J; Wu J
Blood; 2002 Nov; 100(9):3279-86. PubMed ID: 12384428
[TBL] [Abstract][Full Text] [Related]
17. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator.
Mauri DN; Ebner R; Montgomery RI; Kochel KD; Cheung TC; Yu GL; Ruben S; Murphy M; Eisenberg RJ; Cohen GH; Spear PG; Ware CF
Immunity; 1998 Jan; 8(1):21-30. PubMed ID: 9462508
[TBL] [Abstract][Full Text] [Related]
18. DcR3/TR6 modulates immune cell interactions.
Wan X; Shi G; Semenuk M; Zhang J; Wu J
J Cell Biochem; 2003 Jun; 89(3):603-12. PubMed ID: 12761893
[TBL] [Abstract][Full Text] [Related]
19. DcR3/TR6 effectively prevents islet primary nonfunction after transplantation.
Wu Y; Han B; Luo H; Roduit R; Salcedo TW; Moore PA; Zhang J; Wu J
Diabetes; 2003 Sep; 52(9):2279-86. PubMed ID: 12941767
[TBL] [Abstract][Full Text] [Related]
20. Recombinant, soluble LIGHT (HVEM ligand) induces increased IL-8 secretion and growth arrest in A375 melanoma cells.
Hehlgans T; Männel DN
J Interferon Cytokine Res; 2001 May; 21(5):333-8. PubMed ID: 11429164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
